Strengthened margins within all business areas
“Strong profitability has been and continues to be the highest priority, and with a strong financial position we have the prerequisites for investing for the future and continue developing together with our customers.” Nolato Medical has completed a new factory in China and the expansion of the plant in Hungary is running according to plan.” Furthermore, during the quarter we started a production unit within Nolato Telecom in Malaysia for electromagnetic shielding, EMC,” says CEO Hans Porat.
Nolato’s business model is based on a close, long-term and innovative collaboration that creates added value for both customers and shareholders. The strategic work of recent years has resulted in, among other things, market positions moving forward.
“Within Nolato Medical we are continuing our investment in further profitable growth, both organic and through acquisitions. Within Nolato Telecom we will strengthen our niche position with technically advanced solutions and within the area electromagnetic shielding, EMC, while we will move forward the positions with larger selected customers in Northern and Central Europe within Nolato Industrial,” says CEO Hans Porat.
At the end of the second quarter, the equity/assets ratio amounted to 51% (42) and the net financial debt to SEK 37 million (128).
For further information, please contact:
Hans Porat, President and CEO, +46 705 517550
Per-Ola Holmström, CFO, +46 705 763340
Nolato is a Swedish group operating in Europe, Asia and North America. Sales in 2013 amounted to SEK 4.5 billion. We develop and manufacture products made from polymer materials such as plastic, silicone and TPE for leading customers in medical technology, pharmaceuticals, telecoms, automotive, hygiene and other selected industrial sectors. Nolato shares are listed on NASDAQ OMX Stockholm, where Nolato is a Mid Cap company in the Industrials sector.
The information is such which Nolato AB is obliged to disclose under the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. This information was made public on 21 July 2014 at 2.30 pm.